Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases.
dc.contributor.author | Yorozu, A | |
dc.contributor.author | Sykes, Andrew J | |
dc.contributor.author | Slevin, Nicholas J | |
dc.date.accessioned | 2009-10-12T17:08:54Z | |
dc.date.available | 2009-10-12T17:08:54Z | |
dc.date.issued | 2001-09 | |
dc.identifier.citation | Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases. 2001, 37 (6):493-7 Oral Oncol. | en |
dc.identifier.issn | 1368-8375 | |
dc.identifier.pmid | 11435175 | |
dc.identifier.uri | http://hdl.handle.net/10541/84088 | |
dc.description.abstract | There are few studies reporting the results of radical radiotherapy for carcinoma of the hard palate. We have examined our results of patients treated within a single institution, and assessed survival, local control and morbidity. A retrospective analysis was made on 31 patients with hard palate carcinoma treated with external beam radiotherapy at the Christie Hospital between 1990 and 1997. Twenty-six patients received radiotherapy alone and five were treated for post-operative positive surgical margins. The 5-year actuarial survival rate was 55%. The actuarial 5-year local control rate was 53%, rising up to 69% after salvage surgery. Survival was 48% for squamous cell carcinomas and 63% for salivary gland carcinomas, the difference was not significant. The only significant predictor of local control was T-stage, with 80% 5-year local control of T1-2 lesions and 24% control of T3-4 lesions. N-stage was the only significant factor predicting for survival. Radiation necrosis occurred in one patient. Radical radiotherapy for carcinoma of the hard palate is safe and well tolerated. It is an effective treatment for both squamous cell carcinoma and salivary gland carcinoma. | |
dc.language.iso | en | en |
dc.subject | Cancer Staging | en |
dc.subject | Palatal Cancer | en |
dc.subject | Salivary Gland Cancer | en |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Carcinoma, Adenoid Cystic | |
dc.subject.mesh | Carcinoma, Squamous Cell | |
dc.subject.mesh | Combined Modality Therapy | |
dc.subject.mesh | Disease-Free Survival | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Palatal Neoplasms | |
dc.subject.mesh | Palate, Hard | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | Salivary Gland Neoplasms | |
dc.subject.mesh | Survival Rate | |
dc.title | Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases. | en |
dc.type | Article | en |
dc.contributor.department | Christie Hospital, Wilmslow Road, M20 4BX, Manchester, UK. | en |
dc.identifier.journal | Oral Oncology | en |
html.description.abstract | There are few studies reporting the results of radical radiotherapy for carcinoma of the hard palate. We have examined our results of patients treated within a single institution, and assessed survival, local control and morbidity. A retrospective analysis was made on 31 patients with hard palate carcinoma treated with external beam radiotherapy at the Christie Hospital between 1990 and 1997. Twenty-six patients received radiotherapy alone and five were treated for post-operative positive surgical margins. The 5-year actuarial survival rate was 55%. The actuarial 5-year local control rate was 53%, rising up to 69% after salvage surgery. Survival was 48% for squamous cell carcinomas and 63% for salivary gland carcinomas, the difference was not significant. The only significant predictor of local control was T-stage, with 80% 5-year local control of T1-2 lesions and 24% control of T3-4 lesions. N-stage was the only significant factor predicting for survival. Radiation necrosis occurred in one patient. Radical radiotherapy for carcinoma of the hard palate is safe and well tolerated. It is an effective treatment for both squamous cell carcinoma and salivary gland carcinoma. |